CirChem has been growing earnings at an average annual rate of 19.5%, while the Chemicals industry saw earnings declining at 21.2% annually. Revenues have been growing at an average rate of 52.1% per year.
Key information
19.46%
Earnings growth rate
41.76%
EPS growth rate
Chemicals Industry Growth
12.41%
Revenue growth rate
52.08%
Return on equity
-39.10%
Net Margin
-242.89%
Last Earnings Update
30 Jun 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How CirChem makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
DB:CRB Revenue, expenses and earnings (SEK Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
30 Jun 26
7
-18
8
0
31 Mar 26
8
-16
8
0
31 Dec 25
10
-12
8
0
30 Sep 25
16
-7
8
0
30 Jun 25
25
1
8
0
31 Mar 25
24
1
8
0
31 Dec 24
22
-1
7
0
30 Sep 24
18
-3
7
0
30 Jun 24
8
-12
7
0
31 Mar 24
8
-14
7
0
31 Dec 23
6
-17
8
0
30 Sep 23
3
-22
10
0
30 Jun 23
2
-22
11
0
31 Mar 23
1
-24
13
0
31 Dec 22
1
-23
15
0
30 Sep 22
0
-21
16
0
30 Jun 22
0
-23
17
0
31 Mar 22
0
-19
15
0
31 Dec 21
0
-18
15
0
30 Sep 21
0
-18
14
0
30 Jun 21
0
-14
12
0
31 Mar 21
0
-13
12
0
31 Dec 20
0
-9
9
0
31 Dec 19
0
-3
5
0
31 Dec 18
0
-1
1
0
Quality Earnings: CRB is currently unprofitable.
Growing Profit Margin: CRB is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CRB is unprofitable, but has reduced losses over the past 5 years at a rate of 19.5% per year.
Accelerating Growth: Unable to compare CRB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CRB is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-13.3%).
Return on Equity
High ROE: CRB has a negative Return on Equity (-39.1%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/08/17 20:13
End of Day Share Price
2026/08/14 00:00
Earnings
2026/06/30
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CirChem AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.